�鶹��ý

As the Health Care & Life Sciences sector continues to evolve, organizations across the country should be mindful of recent trends in pharmaceutical litigation. Whether it is antitrust, intellectual property, mass tort litigation, or other litigation issues, �鶹��ý partners Elizabeth Haas, chair of the firm’s Antitrust & Competition Practice Group, Katy Koski, James Matthews, co-chair of �鶹��ý’s Pharmaceuticals & Other Regulated Drugs Area of Focus, and Liane Peterson, co-chair of the firm’s Intellectual Property Litigation Practice Group, and senior counsel Kate Gehl will dive into the trends that are on the rise.

�鶹��ý’s Health Care & Life Sciences Sector and Pharmaceuticals & Other Regulated Drugs Area of Focus will host this informative CLE discussion on the top pharmaceutical litigation trends that are affecting the health care and life sciences industry. This webinar will focus on:

• The novel use of emerging public nuisance law in government enforcement and mass tort litigation.
• The top antitrust issues impacting pharmaceutical litigation.
• Patent litigation over technology enabling COVID-19 vaccines.
• Views of the Supreme Court of the United States on enablement of functional patent claims.

To register, please .

CLE

Applications for accreditation will be submitted to CO, FL, NY, and WI for up to one credit hours (50-minute hour) and CA, IL, TX, UT, and VA for up to one credits hours (60-minute hour). Uniform Certificates of Attendance will be provided to attendees seeking credit in other jurisdictions.

�鶹��ý is an approved MCLE provider in California, Colorado, Illinois, New York, Texas, and Utah.

For purposes of New York CLE credit, this program is appropriate��both newly admitted and experienced attorneys. Certificates of attendance will be distributed to eligible participants approximately eight weeks after the program via email.